Health

Results: 1393-1404 of 6429

ENHERTU® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy

Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System

PR Newswire associated0

AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray

PR Newswire associated0

Study Links Bacterial Load to Pain in Venous Ulcers, Demonstrating Effective Reduction with MolecuLight

BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

Dr Lara Zibners and Thang Vo-Ta co-founded the B-Corp inspired by Lara’s experience from multiple failed IVF cycles.

Pioneering tech to address threatened miscarriage secures NIHR grant to advance clinical trials

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q1 2025

IBSA celebrates 40 years of history: “Drugs in the best form” – a success story that combines innovation with a focus on people

Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.

PR Newswire associated0

Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference

Lupin Announces the Acquisition of Renascience in the United Kingdom

(L-R): Real Chemistry welcomes Camilla Griffiths, President, 21GRAMS Europe; and company vet Mike Nelson assumes new International Client Development role at Real Chemistry.

Real Chemistry Strengthens Presence in Europe with Key Leadership Moves